Titan America SA
NYSE:TTAM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Titan America SA
NYSE:TTAM
|
BE |
|
CVR Partners LP
NYSE:UAN
|
US |
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
CN |
|
Severstal' PAO
OTC:SVJTY
|
RU |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
CN |
Income Statement
Earnings Waterfall
Titan America SA
Income Statement
Titan America SA
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Interest Expense |
26
|
0
|
0
|
0
|
26
|
|
| Revenue |
1 634
N/A
|
2 027
+24%
|
2 456
+21%
|
1 648
-33%
|
1 664
+1%
|
|
| Gross Profit | ||||||
| Cost of Revenue |
(1 218)
|
(1 519)
|
(1 835)
|
(1 221)
|
(1 229)
|
|
| Gross Profit |
417
N/A
|
508
+22%
|
621
+22%
|
427
-31%
|
435
+2%
|
|
| Operating Income | ||||||
| Operating Expenses |
(165)
|
(205)
|
(248)
|
(169)
|
(167)
|
|
| Selling, General & Administrative |
(154)
|
(202)
|
(244)
|
(167)
|
(156)
|
|
| Depreciation & Amortization |
(9)
|
0
|
0
|
0
|
(8)
|
|
| Other Operating Expenses |
(2)
|
(3)
|
(4)
|
(2)
|
(3)
|
|
| Operating Income |
251
N/A
|
303
+21%
|
373
+23%
|
258
-31%
|
268
+4%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
(25)
|
(37)
|
(40)
|
(20)
|
(23)
|
|
| Total Other Income |
(2)
|
3
|
3
|
3
|
0
|
|
| Pre-Tax Income |
224
N/A
|
268
+20%
|
336
+25%
|
241
-28%
|
245
+2%
|
|
| Net Income | ||||||
| Tax Provision |
(58)
|
(69)
|
(85)
|
(62)
|
(59)
|
|
| Income from Continuing Operations |
166
|
199
|
251
|
178
|
185
|
|
| Net Income (Common) |
166
N/A
|
199
+20%
|
251
+26%
|
178
-29%
|
185
+4%
|
|
| EPS (Diluted) |
0.95
N/A
|
1.1
+16%
|
1.35
+23%
|
0.96
-29%
|
1.01
+5%
|
|